Fewer trips to the hospital? new cervical cancer radiation trial aims to cut treatment time
NCT ID NCT07605507
First seen Jun 01, 2026 · Last updated Jun 20, 2026 · Updated 5 times
Summary
This study compares a shorter, higher-dose radiation schedule (hypofractionated) to the standard longer schedule for cervical cancer patients also receiving chemotherapy. The goal is to see if the shorter schedule is just as safe and effective, while reducing the number of hospital visits. Forty participants will be randomly assigned to one of the two radiation approaches, and researchers will track side effects, tumor response, and quality of life over five years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Siriraj Hospital
Bangkok, Bangkok, Thailand
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Radiation therapy (hypofractionated or conventional) with cisplatin chemotherapy
What this could lead to
If successful, this could offer a more convenient treatment option for cervical cancer patients, requiring fewer hospital visits while maintaining safety and effectiveness.
What could go wrong
This is a small, early-phase trial with only 40 participants, so results may not apply to all patients. The higher radiation dose per session could increase side effects, and the study is not designed to prove long-term survival benefits.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.